At 1,000-plus employees, the risk is spread across systems, not just carriers.
Self-funding is close to universal at this size. Pharmacy usually runs on its own track, separate from medical. Stop-loss, ASO fees and network access are where the real decisions live, not the plan brochure. At this size your own claims set the price, which is why a year-round health and cost strategy matters most here.
And the benefits data itself is scattered — payroll, HRIS, the medical carrier, the PBM, often a point solution or two on top. The question at this size is not whether you can get a quote. It is whether anyone is looking across the whole stack instead of renewing each piece on its own schedule.
The vendor list gets long. The accountability shouldn’t.
Above 1,000 lives, almost every structural question has already been answered in favor of self-funding. What is left is harder: coordinating a growing list of vendors, structuring risk deliberately instead of by default, and keeping a multi-state or multinational population consistent.
Funding Architecture
Self-funding is close to universal above 1,000 lives. The open questions shift from whether to self-fund to how the plan is structured — attachment points, reserve requirements, and whether a captive arrangement fits the organization’s risk tolerance.
We build and manage the self-funded plan architecture, including evaluating captive participation where it fits, rather than defaulting to the same structure every renewal.
Pharmacy & Vendor Carve-Outs
At this scale, pharmacy benefits are commonly carved out to a standalone PBM rather than bundled with the medical carrier, because carve-out contracts can be negotiated on more transparent, pass-through pricing than bundled arrangements typically allow.
We negotiate and audit PBM contracts on pass-through pricing and rebate transparency, rather than accepting the bundled default.
Stop-Loss Sophistication
Stop-loss arrangements at this size are individually underwritten and heavily negotiated, and large employers increasingly look at aggregating risk internally, or through a group captive, rather than buying stop-loss on the open market alone every year.
We manage that negotiation and, where it fits, the captive relationship, rather than treating stop-loss as a single annual line item.
Multi-State & Multinational Complexity
See the full compliance calendar and what applies at your size →
Employers this size commonly operate across many states, and sometimes internationally, which means benefits strategy has to account for network adequacy nationally, state-by-state mandate variation, and — where relevant — coordination with international benefits programs.
Licensed well beyond Michigan, we handle multi-state complexity directly, and coordinate with international benefits providers when a client’s population extends outside the U.S., rather than treating it as someone else’s problem.
Data & Systems Integration
At this scale, benefits administration usually runs through HRIS and payroll integrations rather than manual enrollment, and plan performance is tracked through claims data analytics throughout the year rather than at renewal alone.
We work inside your existing HRIS and payroll systems and report on claims trends throughout the year, not only at renewal.
Vendor & Governance Coordination
A benefits program this size typically touches multiple vendors — medical carrier or TPA, PBM, stop-loss carrier, wellness or EAP vendors — and misalignment between them, such as mismatched effective dates or inconsistent eligibility files, is a common source of member-facing errors.
We act as the single point of coordination across every vendor in the program, so eligibility and timing stay aligned instead of depending on whichever vendor notices first.
“Our trend was nine percent” is an average of negotiations nobody ran together.
At this size there is no single renewal, so there is no single trend — and the published local figures do not reach you at all.
Which Baseline Actually Applies
State-filed rates exist only for fully insured groups under fifty, so they are not your comparator in any year. The closer one is the national employer trend, because those surveys are weighted to large employers and most of them are self-funded: roughly nine to ten percent for 2026 before plan-design changes, and six and a half to seven and a half after them. Quoting the lower figure assumes you already went and changed something.
And It Is Really Several Trends
Medical, pharmacy, stop-loss and each carve-out have their own trend, their own vendor and their own renewal date. Stop-loss is the fastest of them — up roughly fourteen to sixteen percent for 2026 depending on deductible, because leveraged trend means your deductible stays put while the claims above it grow. Averaging the components into one number hides which vendor is actually costing you the money.
Which is why the useful exhibit at your size is not one line. It is the national trend, the market you buy each component in, and your own result for each of them, over several years rather than one — so that a good claims year is not mistaken for a good negotiation, or the reverse.
At your size the renewal is not a market number. It is your own year, priced.
A renewal is your own claims experience blended with the carrier’s book rate, and what sets the mix is enrolled contracts, not employees. Full credibility is commonly reached at a thousand — at which point the blend stops being a blend.
| Enrolled Contracts | Your Own Claims | The Book Rate | What That Means |
|---|---|---|---|
| 25 | 2.5% | 97.5% | Your claims year is almost invisible in the rate. |
| 50 | 5% | 95% | About where carriers start releasing claims information at all. |
| 100 | 10% | 90% | Nine tenths of the increase describes the market, not you. |
| 250 | 25% | 75% | Still mostly the book — but one large claimant now shows. |
| 500 | 50% | 50% | The market figure and your own experience carry equal weight. |
| 750 | 75% | 25% | Mostly your own claims. The market number is context now. |
| 1,000+ | 100% | — | The renewal is your own claims experience, priced. |
Most employers above a thousand people sit in the lower shaded rows or past the end of the table entirely, depending on how many of them actually enroll. Each carrier sets its own schedule, and the factor applied to your group is printed on your rate exhibit, usually beside the pooling point. You can run the same arithmetic on your own figures with our renewal decoder.
A national trend figure is evidence about somebody else.
It is the most quoted number in this industry and the least applicable to you. At full credibility your renewal is not the market’s average passed along — it is your own claims, priced. The comparison that means something is your own build-up: the trend applied to a claim that will not recur, the attachment point, how rebates were treated, and the enrollment basis the projection was built on.
And participation is still a rate input, even here.
Headcount does not buy credibility — enrollment does. A large employer with a small share of its people enrolled does not reach the bottom of this table, and thin participation is priced as a risk in its own right rather than treated as neutral. So take-up costs twice over, and it is worth modeling before a renewal rather than discovering afterward.
On a self-funded plan, every overpaid claim is your money.
At this size the plan pays its own claims, so the oversight that matters is the work done after the contract is signed: checking what was paid, what the pharmacy contract actually delivered, and who is still on the file.
Every Claim, Not a Sample
A sampled audit finds patterns, but it can miss the single large overpayment, and on a self-funded plan that overpayment comes out of the employer’s own account.
Through our audit partners we review 100% of medical claims rather than a sample, monitor claims continuously month by month, and pursue recovery of overpayments.
Pharmacy, Bid and Audited
Pharmacy guarantees depend on definitions — what counts as specialty, how rebates are calculated, which claims are excluded — and an incumbent PBM that is never re-bid has little reason to sharpen them.
We run the PBM request for proposal, audit pharmacy claims against the contract’s rebate, discount and dispensing guarantees, and review formulary and specialty definitions before each renewal.
Eligibility, Verified
Dependents who aged out, former employees still on the file and spouses with coverage elsewhere are common findings at this size, and each one is paid for until someone checks.
We arrange dependent eligibility verification at implementation and on a routine basis afterward, not as a one-time sweep.
Actuarial Work
A self-funded plan needs budget rates, COBRA rates and a reserve for claims incurred but not yet paid, set every year — and each of those numbers moves real cash.
We set them with our actuarial partners, alongside claims forecasting, and show your finance team the assumptions behind each figure.
Network choices get the same treatment: we compare network cost and quality data where your people actually live, and our pharmacy benefit consulting runs on the same calendar as the medical renewal.
Compared with employers like you, and explained to the people who use the plan.
Peer-group benchmarking
A national trend figure describes somebody else. We prepare a peer-group benchmarking report comparing your plan design, contributions and costs with employers of similar industry, size and region, drawn from employer surveys and plans submitted directly by employers. It gives your benefits committee a reference point the incumbent carrier did not choose.
Enrollment and communication
Plan changes only work if people understand them. Through our partners we provide licensed benefit counselors on-site or by phone, including Spanish-speaking counselors, along with benefits guides, enrollment microsites, video and employee communications timed to open enrollment.
The coverage decisions large employers are making this year.
Mercer’s national survey of more than 1,700 employers puts 2026 health benefit cost growth at 6.5% after plan changes and nearly 9% without them, the highest since 2010. These are the decisions that cost increase is forcing onto committee agendas.
GLP-1 drugs for weight loss
Among employers with 20,000 or more employees, 64% covered GLP-1s for obesity in 2024, up from 53% a year earlier. The real decision is not yes or no: it is clinical criteria, program requirements and what the pharmacy contract does to the net cost. We model the options against your own pharmacy data.
Specialty and cancer care
Two-thirds of large employers had at least one cancer-care strategy in 2024. The levers are site of care, centers of excellence, navigation and second-opinion programs, measured against your own large-claim history rather than a vendor’s brochure.
Fertility benefits
70% of employers with 20,000 or more employees covered IVF in 2024, and 47% of employers with 500 or more. Design choices — lifetime maximums, an in-plan benefit or a carve-out vendor — also change how those claims interact with stop-loss.
Narrow and high-performance networks
29% of the largest employers offered an EPO in 2024, and 40% of EPO plans used a high-performance network against 10% of traditional PPOs. A narrower network only saves money if it holds up where your employees live, so we test it there first.
Behavioral health access
About two-thirds of large employers say making behavioral healthcare easier to reach is a 2026 priority. Access is also a compliance question, which is why network adequacy and mental health parity belong in the same review.
Measuring what you already bought
Point solutions aimed at the same population often claim the same savings. Before adding another program, we measure the existing portfolio against a baseline you agreed in advance.
Figures: Mercer National Survey of Employer-Sponsored Health Plans, 2024 results and 2026 projections.
If you still cover retirees, they need a strategy of their own.
Retiree medical sits outside the active-employee renewal, but it carries its own cost and its own liability. We place retiree coverage for both age groups and look for the savings the active plan cannot reach.
Retirees under 65
A self-funded group arrangement backed by stop-loss and priced against Medicare rates rather than commercial network discounts, with the option to keep the existing PPO network or use a reference-based pricing approach. Pre-Medicare retiree coverage →
Retirees 65 and older
A fully insured group plan that supplements Medicare, with access to any provider or hospital that accepts Medicare.
Medicare Maximization
Some retirees under 65 qualify for Social Security Disability, and through it for Medicare, without knowing it. We identify them and help move them to Medicare as primary coverage, which lowers what the plan pays and can reduce the retiree medical liability reported on your financial statements. Fees are contingent on success. How it works →
Retiree HRAs
An alternative way to fund retiree coverage, giving retirees a defined amount to spend rather than a plan to maintain. Retiree HRAs →
What employers your size ask us.
How many vendors are we actually supposed to be managing?
At this size, usually five to eight: a medical carrier or TPA, pharmacy, stop-loss, dental, vision, disability, and often a point solution or two. We coordinate them against one strategy instead of you fielding five separate renewal calls. Each contract has its own renewal date and eligibility file, and errors appear where they meet, such as a termination that reaches medical but not dental. One shared calendar and eligibility standard prevents that.
Is self-funding still right for us, or should we consider fully insured for predictability?
At 1,000-plus employees, fully insured is rarely the more efficient option — the premium is pricing in a risk margin you are large enough to carry yourself. The real design question is where you set stop-loss and how ASO fees are structured, not whether to self-fund.
We operate in a dozen states. Does that change who we should be working with?
It should. State mandates, network adequacy and eligibility rules do not get simpler with scale. We are licensed well beyond Michigan, with offices in Michigan, Colorado and Texas, and can support multinational populations directly. At that footprint the network has to be tested where people actually live, and insured lines such as dental or life can carry state mandates that a self-funded medical plan avoids. We map headcount by state before any market check.
At this size the question stops being the rate and becomes the program.
Above a thousand employees you are running several populations under one funding arrangement, and the governance around the plan matters as much as its design. Industry shapes both.
Manufacturing
Several locations and bargaining units, more than one plan design, and a funding structure that has to hold all of them without cross-subsidizing the wrong group. In manufacturing, collectively bargained plans often have their own contribution rules and renewal dates tied to the contract, so the non-union plan should be designed knowing what the union plan offers. Where several populations share the employer’s own plan, we model each one separately, so one group’s claims are visible rather than averaged away.
Health Care and Social Assistance
Large clinical populations where specialty pharmacy and a handful of high-cost claimants drive the result, and where your own employees are also patients in your network. That second point cuts both ways: steering employees into your own system can lower cost, but it also means their care and records sit with colleagues, so privacy controls and plan design need care. Specialty pharmacy strategy and large-claim monitoring can decide as much of the budget as the medical network does.
Management of Companies and Enterprises
Holding structures where each subsidiary arrived with its own plan, its own history and its own idea of what was promised. Bringing them onto one program means deciding what to harmonize, what to grandfather and in what order, since a subsidiary that loses a richer plan will remember it. We inventory each plan’s terms and contracts first, then set a sequence that avoids a mid-year cutover where possible.
Public Administration
Procurement rules, public disclosure and collectively bargained benefits, where the process behind a decision is scrutinized as closely as the decision. Public employers usually buy through formal requests for proposal with scoring criteria set in advance, and the file may be open to public records requests. We build the market process and the documentation so the record shows how each option was evaluated, and we plan design changes around bargaining timelines.
Every sector we serve
- Accommodation and Food Services
- Administrative and Support and Waste Management
- Agriculture, Forestry, Fishing and Hunting
- Arts, Entertainment, and Recreation
- Construction
- Educational Services
- Finance and Insurance
- Health Care and Social Assistance
- Information
- Management of Companies and Enterprises
- Manufacturing
- Mining, Quarrying, and Oil and Gas Extraction
- Mortgage lending
- Other Services
- Professional, Scientific, and Technical Services
- Public Administration
- Real Estate and Rental and Leasing
- Retail Trade
- Transportation and Warehousing
- Utilities
- Wholesale Trade
At this scale the questions are about governance, not coverage
Ten questions from large employers about running the program rather than buying it.
What should a benefits committee actually see each quarter?
Enough to make decisions and to show later how they were made. Plan performance against budget with the drivers separated, the large-claim picture and what is ongoing, pharmacy split between traditional and specialty, vendor service levels against contract, an open compliance calendar, and any fee disclosures received since the last meeting. Minutes that record what was considered are as valuable as the pack itself.
How often should we run a proper vendor RFP, and for what?
Administration and pharmacy on a multi-year cycle, stop-loss annually in the market even when you expect to stay. The point is not constant switching, which carries real disruption cost, but keeping incumbents priced as though they could be replaced. The second point is documentation – a periodic competitive process is the clearest evidence that fees were tested.
Is a captive worth considering at our size?
At this size you are usually large enough to self-insure the working layer comfortably, so the question becomes what you do with the stop-loss layer and whether pooling it with similar employers beats buying it. Captives reward employers with stable workforces, genuine appetite for plan management and a multi-year horizon. They punish employers looking for a one-year saving.
How should we think about pharmacy rebates?
As a question about flow, not size. Where do rebates go, on what lag, on which drugs, and who audits the calculation. A large headline rebate guarantee can coexist with a contract that keeps the economics with the manager. The related question is how specialty is defined, because definitions drive which drugs the guarantees actually cover.
What does the compensation disclosure requirement mean for us in practice?
Brokers and consultants must disclose to the plan sponsor, in writing, the direct and indirect compensation they expect to receive in connection with the plan. Your job is to receive it, read it, and record that you assessed whether the arrangement is reasonable for the services delivered. It is a light obligation to meet and an awkward one to have ignored, and it is the easiest place to start a fee review.
How do we manage benefits across union and non-union populations?
As separate design problems with a shared administration. Collectively bargained benefits are set at the table and change on the contract’s clock, not the plan year’s, and a multiemployer fund may sit outside your plan entirely. The practical risks are eligibility feeds that assume one population, and compliance reporting that has to cover people whose benefits you do not control.
What do we do about high-cost specialty drugs?
Know what you have before you design around it. Specialty is a small number of prescriptions carrying a large share of pharmacy spend, and the levers differ by drug – site of care, whether it is billed under the medical or pharmacy benefit, clinical review at initiation, and how biosimilars are positioned in the formulary. Blanket exclusions rarely survive contact with an appeal.
How do we tell whether a point solution is earning its keep?
Agree the measure before it launches, not after. That means a baseline, a defined population, and a definition of savings you would accept from a stranger. Engagement rates are an input, not an outcome. Several solutions aimed at the same population will also claim the same avoided costs, so the portfolio needs measuring as a whole.
What does an eligibility audit typically find?
Terminated employees still on the file, dependents who aged out, and students no longer enrolled – and at this size the cost of that is real money rather than a rounding error. The root cause is almost always the handoff between payroll and benefits, particularly termination reasons, which is why the fix is a data-flow fix rather than a one-off cleanup.
Who should own benefits data in a company our size?
Someone accountable for it who is not the carrier. In practice that means agreeing where the system of record sits, who reconciles it against payroll and on what cycle, and who is allowed to change eligibility. When nobody owns it, the eligibility file becomes the de facto record and errors are only discovered when a claim is denied.
Want this on your own numbers? Send us your renewal, or talk it through with someone first. No cost, no obligation.
General information about group benefits, not legal or tax advice. Plan-specific questions belong with ERISA counsel, and we will bring them in.
Corporate Benefits Consulting in Bloomfield Hills for Large Employers Who Want Real Answers
Large employers spend a great deal on health benefits, yet many still get a renewal with little detail and a vendor list no one has reviewed in years. Corporate benefits consulting in Bloomfield Hills should give your HR and finance teams clear data and a plan they can defend to leadership.
We are CFH Insurance Consultants, an independent employee benefits consulting firm on Woodward Avenue, in business since 2007. No carrier owns us. We work with large employers in Metro Detroit, Oakland County and across Michigan, including companies with staff in other states.
Corporate Benefits Consulting
At this size, most employers self-fund. That means the company pays claims directly and buys stop-loss insurance to cap large claims. The work shifts from shopping premiums to managing vendors and data.
Here is how we help:
- Pharmacy. We review your pharmacy benefit manager (PBM) contract, including rebates and pricing terms.
- Stop-loss and funding. We market your stop-loss and test your funding setup each year.
- Direct contracting. We look at direct deals with health systems and centers of excellence for high-cost care.
- Governance. Under ERISA, plan fiduciaries must act in members’ best interest. We help set up a benefits committee and keep records of decisions.
- Multi-state plans. We help you line up coverage and rules for employees outside Michigan.
We are not the plan administrator. A third-party administrator pays claims, and we find, set up and oversee each vendor for you.
What should a large employer ask a benefits consultant?
Ask how they are paid, how they review the PBM contract, and who will actually work on your account. Ask to see a sample of the claims reporting they give clients. The answers tell you whether you are getting advice or just a quote.
Common questions
Do you replace our internal benefits team?
No. We work alongside your HR and finance teams and add depth where they need it. Your team keeps ownership of the plan and the decisions, and we supply the market work, analysis and vendor coordination that is hard to staff internally for every renewal. A service team of five covers the account, so your staff have one route for escalations and a record of what was decided.
Can clients reach CPAs and ERISA attorneys?
Yes. Clients get access to CPAs and ERISA attorneys through the firm. At this size they are most useful on questions such as a plan document amendment, a nondiscrimination issue, a fee disclosure or a controlled-group question in an acquisition. We bring them in when a decision has legal or tax consequences, and keep your own counsel informed so advice does not conflict.
Talk to us about corporate benefits consulting in Bloomfield Hills
Book a 30-minute call with your benefits and finance leads. Our office is at 41000 Woodward Avenue, Suite 350 East, Bloomfield Hills, MI 48304. Call 248.370.8853.
Send us your renewal.
We’ll benchmark your program, map the vendor stack against one strategy, and tell you where the money and the risk actually sit. No cost, and no obligation to move anything.
An independent employee benefits consulting firm. We look at the entire benefits program — cost, plan performance, risk and administration.
Switch to CFH. Unhappy with your broker? Your employees won’t notice. You will. →